Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway

Ji,Hui; Li,Hui; Zhang,Haixia; Cheng,Zhijun

doi:10.3892/mmr.2021.12517

Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway

Authors:
- Hui Ji
- Hui Li
- Haixia Zhang
- Zhijun Cheng
View Affiliations

Affiliations: Department of Anesthesiology, Xinhua Hospital, Chongming Branch, Shanghai 202150, P.R. China
Published online on: November 1, 2021 https://doi.org/10.3892/mmr.2021.12517
Article Number: 1
Copyright: © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatic ischemia/reperfusion (I/R) injury (HIRI) often occurs following tissue resection, hemorrhagic shock or transplantation surgery. Previous investigations showed that sevoflurane (Sevo), an inhalation anesthetic, had protective properties against different organ damage in animal models including HIRI. This study is aimed to investigate the underlying mechanisms involved in the protective effects of Sevo on HIRI. The present study results showed that treatment with Sevo improved histologic damage, inflammatory response, oxidative stress and apoptosis after hepatic I/R, indicating the protective role of Sevo against liver I/R injury. Importantly, in order to determine the molecular mechanism of Sevo in HIRI, the focus of the study was on microRNA (miR) regulation. By retrieving the microarray data in the Gene Expression Omnibus dataset (GSE72315), miR‑218‑5p was found to be significantly downregulated by Sevo. Moreover, miR‑218‑5p overexpression using agomiR‑218‑5p reversed the protective roles of Sevo against HIRI. Furthermore, GAB2, a positive regulator of PI3K/AKT signaling pathway, was found as a target gene of miR‑218‑5p. It was also found that the Sevo‑mediated protective effects may be dependent on the activation of GAB2/PI3K/AKT. Collectively, these data revealed that Sevo alleviated HIRI in mice by restraining apoptosis, relieving oxidative stress and inflammatory response through the miR‑218‑5p/GAB2/PI3K/AKT pathway, which helps in understanding the novel mechanism of the hepatic‑protection of Sevo.

View Figures

View References

1	Jaeschke H: Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 284:G15–G26. 2003. View Article : Google Scholar : PubMed/NCBI
2	Jaeschke H and Woolbright BL: Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando). 26:103–114. 2012. View Article : Google Scholar : PubMed/NCBI
3	Li XJ and Ye QF: Fucoidan reduces inflammatory response in a rat model of hepatic ischemia-reperfusion injury. Can J Physiol Pharmacol. 93:999–1005. 2015. View Article : Google Scholar : PubMed/NCBI
4	Datta G, Fuller BJ and Davidson BR: Molecular mechanisms of liver ischemia reperfusion injury: Insights from transgenic knockout models. World J Gastroenterol. 19:1683–1698. 2013. View Article : Google Scholar : PubMed/NCBI
5	Kersten JR, Schmeling TJ, Hettrick DA, Pagel PS, Gross GJ and Warltier DC: Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology. 85:794–807; discussion 27A. 1996. View Article : Google Scholar : PubMed/NCBI
6	Schlack W, Preckel B, Barthel H, Obal D and Thamer V: Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo. Br J Anaesth. 79:88–96. 1997. View Article : Google Scholar : PubMed/NCBI
7	Jeong JS, Kim D, Kim KY, Ryu S, Han S, Shin BS, Kim GS, Gwak MS and Ko JS: Ischemic preconditioning produces comparable protection against hepatic ischemia/reperfusion injury under isoflurane and sevoflurane anesthesia in rats. Transplant Proc. 49:2188–2193. 2017. View Article : Google Scholar : PubMed/NCBI
8	Zhang Y, Shan Z, Zhao Y and Ai Y: Sevoflurane prevents miR-181a-induced cerebral ischemia/reperfusion injury. Chem Biol Interact. 308:332–338. 2019. View Article : Google Scholar : PubMed/NCBI
9	Ohsumi A, Marseu K, Slinger P, McRae K, Kim H, Guan Z, Hwang DM, Liu M, Keshavjee S and Cypel M: Sevoflurane attenuates ischemia-reperfusion injury in a rat lung transplantation model. Ann Thorac Surg. 103:1578–1586. 2017. View Article : Google Scholar : PubMed/NCBI
10	Liu C, Ding R, Huang W, Miao L, Li J and Li Y: Sevoflurane protects against intestinal ischemia-reperfusion injury by activating peroxisome proliferator-activated receptor gamma/nuclear factor-κB pathway in rats. Pharmacology. 105:231–242. 2020. View Article : Google Scholar : PubMed/NCBI
11	Zheng B, Zhan Q, Chen J, Xu H and He Z: Sevoflurane pretreatment enhance HIF-2α expression in mice after renal ischemia/reperfusion injury. Int J Clin Exp Pathol. 8:13114–13119. 2015.PubMed/NCBI
12	Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, Bedirli A, Ozlu O and Pasaoglu H: Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg. 106:830–837. 2008. View Article : Google Scholar : PubMed/NCBI
13	Li J, Yuan T, Zhao X, Lv GY and Liu HQ: Protective effects of sevoflurane in hepatic ischemia-reperfusion injury. Int J Immunopathol Pharmacol. 29:300–307. 2016. View Article : Google Scholar : PubMed/NCBI
14	Shiraishi S, Cho S, Akiyama D, Ichinomiya T, Shibata I, Yoshitomi O, Maekawa T, Ozawa E, Miyaaki H and Hara T: Sevoflurane has postconditioning as well as preconditioning properties against hepatic warm ischemia-reperfusion injury in rats. J Anesth. 33:390–398. 2019. View Article : Google Scholar : PubMed/NCBI
15	Beck-Schimmer B, Roth Z'graggen B, Booy C, Köppel S, Spahn DR, Schläpfer M and Schadde E: Sevoflurane protects hepatocytes from ischemic injury by reducing reactive oxygen species signaling of hepatic stellate cells: Translational findings based on a clinical trial. Anesth Analg. 127:1058–1065. 2018. View Article : Google Scholar : PubMed/NCBI
16	Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 96 (Suppl 1):R40–R44. 2007.PubMed/NCBI
17	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
18	Xiao Y, Zhang S, Li Q, Liu Z, Mai W, Chen W, Lei J and Hu H: miR-219a-5p Ameliorates hepatic ischemia/reperfusion injury via impairing TP53BP2. Dig Dis Sci. 64:2177–2186. 2019. View Article : Google Scholar : PubMed/NCBI
19	Xing Y, Li J, Li SP, Xi J, Ma N, Liu L, Wang JS and Cai JZ: MiR-27a-5p regulates apoptosis of liver ischemia-reperfusion injury in mice by targeting Bach1. J Cell Biochem. 119:10376–10383. 2018. View Article : Google Scholar : PubMed/NCBI
20	Yuan J and Zhang Y: Sevoflurane reduces inflammatory factor expression, increases viability and inhibits apoptosis of lung cells in acute lung injury by microRNA-34a-3p upregulation and STAT1 downregulation. Chem Biol Interact. 322:1090272020. View Article : Google Scholar : PubMed/NCBI
21	Xu C, Niu JJ, Zhou JF and Wei YS: MicroRNA-96 is responsible for sevoflurane-induced cognitive dysfunction in neonatal rats via inhibiting IGF1R. Brain Res Bull. 144:140–148. 2019. View Article : Google Scholar : PubMed/NCBI
22	Zhao YB, Zhao J, Zhang LJ, Shan RG, Sun ZZ, Wang K, Chen JQ and Mu JX: MicroRNA-370 protects against myocardial ischemia/reperfusion injury in mice following sevoflurane anesthetic preconditioning through PLIN5-dependent PPAR signaling pathway. Biomed Pharmacother. 113:1086972019. View Article : Google Scholar : PubMed/NCBI
23	Tan DX, Chen XX, Bai TZ, Zhang J and Li ZF: Sevoflurane up-regulates microRNA-204 to ameliorate myocardial ischemia/reperfusion injury in mice by suppressing Cotl1. Life Sci. 259:1181622020. View Article : Google Scholar : PubMed/NCBI
24	Liao X, Zhou S, Zong J and Wang Z: Sevoflurane exerts protective effects on liver ischemia/reperfusion injury by regulating NFKB3 expression via miR-9-5p. Exp Ther Med. 17:2632–2640. 2019.PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Li XF, Wang ZQ, Li LY, Zhao GQ and Yu SN: Downregulation of the long noncoding RNA MBNL1-AS1 protects sevoflurane-pretreated mice against ischemia-reperfusion injury by targeting KCNMA1. Exp Mol Med. 50:1152018. View Article : Google Scholar : PubMed/NCBI
27	Shi CX, Ding YB, Jin FYJ, Li T, Ma JH, Qiao LY, Pan WZ and Li KZ: Effects of sevoflurane post-conditioning in cerebral ischemia-reperfusion injury via TLR4/NF-κB pathway in rats. Eur Rev Med Pharmacol Sci. 22:1770–1775. 2018.PubMed/NCBI
28	Hao YL, Fang HC, Zhao HL, Li XL, Luo Y, Wu BQ, Fu MJ, Liu W, Liang JJ and Chen XH: The role of microRNA-1 targeting of MAPK3 in myocardial ischemia-reperfusion injury in rats undergoing sevoflurane preconditioning via the PI3K/Akt pathway. Am J Physiol Cell Physiol. 315:C380–C388. 2018. View Article : Google Scholar : PubMed/NCBI
29	Qiao SG, Sun Y, Sun B, Wang A, Qiu J, Hong L, An JZ, Wang C and Zhang HL: Sevoflurane postconditioning protects against myocardial ischemia/reperfusion injury by restoring autophagic flux via an NO-dependent mechanism. Acta Pharmacol Sin. 40:35–45. 2019. View Article : Google Scholar : PubMed/NCBI
30	Ming N, Na HST, He JL, Meng QT and Xia ZY: Propofol alleviates oxidative stress via upregulating lncRNA-TUG1/Brg1 pathway in hypoxia/reoxygenation hepatic cells. J Biochem. 166:415–421. 2019. View Article : Google Scholar : PubMed/NCBI
31	Wenlan L, Zhongyuan X, Shaoqing L, Liying Z, Bo Z and Min L: MiR-34a-5p mediates sevoflurane preconditioning induced inhibition of hypoxia/reoxygenation injury through STX1A in cardiomyocytes. Biomed Pharmacother. 102:153–159. 2018. View Article : Google Scholar : PubMed/NCBI
32	Hao W, Zhao ZH, Meng QT, Tie ME, Lei SQ and Xia ZY: Propofol protects against hepatic ischemia/reperfusion injury via miR-133a-5p regulating the expression of MAPK6. Cell Biol Int. 41:495–504. 2017. View Article : Google Scholar : PubMed/NCBI
33	Xiong L, Yu KH and Zhen SQ: MiR-93 blocks STAT3 to alleviate hepatic injury after ischemia-reperfusion. Eur Rev Med Pharmacol Sci. 22:5295–5304. 2018.PubMed/NCBI
34	Wu Y, Gu C and Huang X: Sevoflurane protects against hepatic ischemia/reperfusion injury by modulating microRNA-200c regulation in mice. Biomed Pharmacother. 84:1126–1136. 2016. View Article : Google Scholar : PubMed/NCBI
35	Li S, Zhang J, Wang Z, Wang T, Yu Y, He J, Zhang H, Yang T and Shen Z: MicroRNA-17 regulates autophagy to promote hepatic ischemia/reperfusion injury via suppression of signal transductions and activation of transcription-3 expression. Liver Transpl. 22:1697–1709. 2016. View Article : Google Scholar : PubMed/NCBI
36	Tian J, Zhang H, Mu L, Wang M, Li X, Zhang X, Xie E, Ma M, Wu D and Du Y: The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer. Exp Cell Res. 394:1121282020. View Article : Google Scholar : PubMed/NCBI
37	Shi L, Sun X, Zhang J, Zhao C, Li H, Liu Z, Fang C, Wang X, Zhao C, Zhang X, et al: Gab2 expression in glioma and its implications for tumor invasion. Acta Oncol. 52:1739–1750. 2013. View Article : Google Scholar : PubMed/NCBI
38	Liu T, Zhang Q, Mo W, Yu Q, Xu S, Li J, Li S, Feng J, Wu L, Lu X, et al: The protective effects of shikonin on hepatic ischemia/reperfusion injury are mediated by the activation of the PI3K/Akt pathway. Sci Rep. 7:447852017. View Article : Google Scholar : PubMed/NCBI
39	Li S, Yi Z, Deng M, Scott MJ, Yang C, Li W, Lei Z, Santerre NM, Loughran P and Billiar TR: TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway. JCI Insight. 4:e1290132019. View Article : Google Scholar : PubMed/NCBI
40	Zuniga J, Venegas F, Villarreal M, Núñez D, Chandía M, Valenzuela R, Tapia G, Varela P, Videla LA and Fernández V: Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat. Free Radic Res. 44:854–863. 2010. View Article : Google Scholar : PubMed/NCBI
41	Mardones M, Valenzuela R, Romanque P, Covarrubias N, Anghileri F, Fernández V, Videla LA and Tapia G: Prevention of liver ischemia reperfusion injury by a combined thyroid hormone and fish oil protocol. J Nutr Biochem. 23:1113–1120. 2012. View Article : Google Scholar : PubMed/NCBI
42	Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, Hua F, Xu G and Yu P: Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep. 4:73172014. View Article : Google Scholar : PubMed/NCBI
43	Takemori K, Kobayashi K and Sakamoto A: Expression of pulmonary vasoactive factors after sevoflurane anaesthesia in rats: A quantitative real-time polymerase chain reaction study. Br J Anaesth. 100:190–194. 2008. View Article : Google Scholar : PubMed/NCBI
44	Yu P, Zhang J, Yu S, Luo Z, Hua F, Yuan L, Zhou Z, Liu Q, Du X, Chen S, et al: Protective effect of sevoflurane postconditioning against cardiac ischemia/reperfusion injury via ameliorating mitochondrial impairment, oxidative stress and rescuing autophagic clearance. PLoS One. 10:e01346662015. View Article : Google Scholar : PubMed/NCBI
45	Mikrou A, Kalimeris KA, Lilis I, Papoutsidakis N, Nastos K, Papadaki H, Kostopanagiotou GG and Zarkadis IK: Molecular studies of the immunological effects of the sevoflurane preconditioning in the liver and lung in a rat model of liver ischemia/reperfusion injury. Mol Immunol. 72:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
46	Huang G, Hao F and Hu X: Downregulation of microRNA-155 stimulates sevoflurane-mediated cardioprotection against myocardial ischemia/reperfusion injury by binding to SIRT1 in mice. J Cell Biochem. 120:15494–15505. 2019. View Article : Google Scholar : PubMed/NCBI
47	Zhu H, Wang X and Chen S: Downregulation of miR-218-5p protects against oxygen-glucose deprivation/reperfusion-induced injuries of PC12 cells via upregulating N-myc downstream regulated gene 4 (NDRG4). Med Sci Monit. 26:e9201012020. View Article : Google Scholar : PubMed/NCBI
48	Su SS, Li BP, Li CL, Xiu FR, Wang DY and Zhang FR: Downregulation of MiR-218 can alleviate high-glucose-induced renal proximal tubule injury by targeting GPRC5A. Biosci Biotechnol Biochem. 84:1123–1130. 2020. View Article : Google Scholar : PubMed/NCBI
49	Li L and Zhao G: Downregulation of microRNA-218 relieves neuropathic pain by regulating suppressor of cytokine signaling 3. Int J Mol Med. 37:851–858. 2016. View Article : Google Scholar : PubMed/NCBI
50	Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, Dhaun N, Webb DJ, Costello EM, et al: Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 54:1767–1776. 2011. View Article : Google Scholar : PubMed/NCBI
51	Rao J, Qian X, Li G, Pan X, Zhang C, Zhang F, Zhai Y, Wang X and Lu L: ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/reperfusion injury. Am J Transplant. 15:76–87. 2015. View Article : Google Scholar : PubMed/NCBI
52	Park SW, Chen SW, Kim M, Brown KM, D'Agati VD and Lee HT: Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice. J Pharmacol Exp Ther. 333:736–747. 2010. View Article : Google Scholar : PubMed/NCBI
53	Adams SJ, Aydin IT and Celebi JT: GAB2-a scaffolding protein in cancer. Mol Cancer Res. 10:1265–1270. 2012. View Article : Google Scholar : PubMed/NCBI
54	Li Z, Zhao F, Cao Y, Zhang J, Shi P, Sun X, Zhang F and Tong L: DHA attenuates hepatic ischemia reperfusion injury by inhibiting pyroptosis and activating PI3K/Akt pathway. Eur J Pharmacol. 835:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
55	Li H, Chen O, Ye Z, Zhang R, Hu H, Zhang N, Huang J, Liu W and Sun X: Inhalation of high concentrations of hydrogen ameliorates liver ischemia/reperfusion injury through A_2A receptor mediated PI3K-Akt pathway. Biochem Pharmacol. 130:83–92. 2017. View Article : Google Scholar : PubMed/NCBI
56	Mu L, Guan B, Tian J, Li X, Long Q, Wang M, Wang W, She J, Li X, Wu D and Du Y: MicroRNA218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2. Oncol Rep. 44:1961–1970. 2020.PubMed/NCBI
57	Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E, Missiroli S, Patergnani S, Poletti F, et al: Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct. 2012:3296352012. View Article : Google Scholar : PubMed/NCBI
58	Quoilin C, Mouithys-Mickalad A, Lecart S, Fontaine-Aupart MP and Hoebeke M: Evidence of oxidative stress and mitochondrial respiratory chain dysfunction in an in vitro model of sepsis-induced kidney injury. Biochim Biophys Acta. 1837:1790–1800. 2014. View Article : Google Scholar : PubMed/NCBI
59	Ortiz M, Soto-Alarcon SA, Orellana P, Espinosa A, Campos C, López-Arana S, Rincón MA, Illesca P, Valenzuela R and Videla LA: Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration. Dig Liver Dis. 52:895–904. 2020. View Article : Google Scholar : PubMed/NCBI
60	Okatani Y, Wakatsuki A, Enzan H and Miyahara Y: Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver. Eur J Pharmacol. 465:163–170. 2003. View Article : Google Scholar : PubMed/NCBI
61	Mukhopadhyay P, Horvath B, Zsengeller Z, Bátkai S, Cao Z, Kechrid M, Holovac E, Erdėlyi K, Tanchian G, Liaudet L, et al: Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: Therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med. 53:1123–1138. 2012. View Article : Google Scholar : PubMed/NCBI